<p>A compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R1 to R9 are as defined in the specification and which compound has an Alphabeta production inhibitory effect and may be useful as a prophylactic or therapeutic agent for a neurodegenerative disease caused by Alphabeta and typified by Alzheimer-type dementia (AD) or Down's syndrome.</p>
申请公布号
WO2014013076(A1)
申请公布日期
2014.01.23
申请号
WO2013EP65352
申请日期
2013.07.19
申请人
EISAI R&D MANAGEMENT CO., LTD.;HALL, ADRIAN;FARTHING, CHRISTOPHER NEIL;EATHERTON, ANDREW JOHN
发明人
HALL, ADRIAN;FARTHING, CHRISTOPHER NEIL;EATHERTON, ANDREW JOHN